Journal
JOURNAL OF INFLAMMATION RESEARCH
Volume 3, Issue -, Pages 127-134Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JIR.S13394
Keywords
PPAR-gamma; antiglomerular basement membrane disease
Categories
Ask authors/readers for more resources
Activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPAR-gamma) has been shown to be immunoregulatory in autoimmune diseases by inhibiting production of a number of inflammatory mediators. We investigated whether PPAR-gamma gene deletion in hematopoietic cells would alter disease pathogenesis in the antiglomerular basement membrane (anti-GBM) mouse model. PPAR-gamma(+/+) and PPAR-gamma(-/-)mice were immunized with rabbit antimouse GBM antibodies and lipopolysaccharide and evaluated for two weeks. Although both the PPAR-gamma(+/+) and PPAR-gamma(-/-)mice had IgG deposition in the glomerulus and showed proteinuria two weeks after injection, glomerular and tubulointerstitial disease in PPAR-gamma(-/-)mice were significantly more severe compared with the PPAR-gamma(+/+) animals. We observed that the PPAR-gamma(-/-)mice had decreased CD4(+) CD25(+) regulatory T cells and an increased CD8(+): CD4(+) ratio as compared with the PPAR-gamma(+/+) mice, suggesting that PPAR-. has a role in the regulation of T cells. Furthermore, plasma interleukin-6 levels were significantly increased in the PPAR-gamma(-/-)mice at two weeks as compared with the PPAR-gamma(+/+) animals. Taken together, these studies show that the lack of PPAR-gamma expression enhances inflammatory renal disease in the anti-GBM antibody-induced glomerulonephritis mouse model and suggests targeting PPAR-gamma may have therapeutic efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available